← Eichor
Study identifier: NCT03987308 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients

Condition: Type 2 Diabetic Patients · T2DM (Type 2 Diabetes Mellitus) · T2DM  ·  Sponsor: Beijing Hospital

PhaseNA
Planned participants115
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The efficacy, safety and post-treatment disease control will be compared between groups of continuous subcutaneous Beinaglutide infusion and continuous subcutaneous insulin infusion (CSII) in adult patients with newly diagnosed type 2 diabetes.

This description comes directly from the study's public registry record.

Talk to the study team

Lixin Guo, M.D.,Ph.D.  ·  +8613901317569  ·  glx1218@163.com

Dongni Yu, M.D.  ·  +8613621273587  ·  yudongni@outlook.com

Always discuss trial participation with your own doctor first.

Locations (16)

Pinggu District HospitalBeijing, Beijing Municipality, ChinaRecruiting
Capital Medical University Beijing Anzhen HospitalBeijing, Beijing Municipality, ChinaRecruiting
Emergency General HospitalBeijing, Beijing Municipality, ChinaRecruiting
Peking University Shougang HospitalBeijing, Beijing Municipality, ChinaRecruiting
Southern Medical University Nanfang HospitalGuangzhou, Guangdong, ChinaRecruiting
Harbin Medical University Second HospitalHarbin, Heilongjiang, ChinaRecruiting
Southeast University Zhongda HospitalNanjing, Jiangsu, ChinaRecruiting
Xuzhou Medical University Affiliated HospitalXuzhou, Jiangsu, ChinaRecruiting
China-Japan Union Hospital of Jilin UniversityChangchun, Jilin, ChinaRecruiting
Jilin University Second HospitalChangchun, Jilin, ChinaRecruiting
Xi'an Jiaotong University Second HospitalXi'an, Shaanxi, ChinaRecruiting
Southwest Medical University Affiliated HospitalLuzhou, Sichuan, ChinaRecruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03987308